Cargando…
A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington’s Disease
BACKGROUND: Huntington’s disease is an inherited neurodegenerative disorder characterised by motor, cognitive and psychiatric disturbances. Patients exhibit other symptoms including sleep and mood disturbances, muscle atrophy and weight loss which may be linked to hypothalamic pathology and dysfunct...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592185/ https://www.ncbi.nlm.nih.gov/pubmed/26431314 http://dx.doi.org/10.1371/journal.pone.0138848 |
_version_ | 1782393172577484800 |
---|---|
author | Kalliolia, Eirini Silajdžić, Edina Nambron, Rajasree Costelloe, Seán J. Martin, Nicholas G. Hill, Nathan R. Frost, Chris Watt, Hilary C. Hindmarsh, Peter Björkqvist, Maria Warner, Thomas T. |
author_facet | Kalliolia, Eirini Silajdžić, Edina Nambron, Rajasree Costelloe, Seán J. Martin, Nicholas G. Hill, Nathan R. Frost, Chris Watt, Hilary C. Hindmarsh, Peter Björkqvist, Maria Warner, Thomas T. |
author_sort | Kalliolia, Eirini |
collection | PubMed |
description | BACKGROUND: Huntington’s disease is an inherited neurodegenerative disorder characterised by motor, cognitive and psychiatric disturbances. Patients exhibit other symptoms including sleep and mood disturbances, muscle atrophy and weight loss which may be linked to hypothalamic pathology and dysfunction of hypothalamo-pituitary axes. METHODS: We studied neuroendocrine profiles of corticotropic, somatotropic and gonadotropic hypothalamo-pituitary axes hormones over a 24-hour period in controlled environment in 15 healthy controls, 14 premanifest and 13 stage II/III Huntington’s disease subjects. We also quantified fasting levels of vasopressin, oestradiol, testosterone, dehydroepiandrosterone sulphate, thyroid stimulating hormone, free triiodothyronine, free total thyroxine, prolactin, adrenaline and noradrenaline. Somatotropic axis hormones, growth hormone releasing hormone, insulin-like growth factor-1 and insulin-like factor binding protein-3 were quantified at 06:00 (fasting), 15:00 and 23:00. A battery of clinical tests, including neurological rating and function scales were performed. RESULTS: 24-hour concentrations of adrenocorticotropic hormone, cortisol, luteinizing hormone and follicle-stimulating hormone did not differ significantly between the Huntington’s disease group and controls. Daytime growth hormone secretion was similar in control and Huntington’s disease subjects. Stage II/III Huntington’s disease subjects had lower concentration of post-sleep growth hormone pulse and higher insulin-like growth factor-1:growth hormone ratio which did not reach significance. In Huntington’s disease subjects, baseline levels of hypothalamo-pituitary axis hormones measured did not significantly differ from those of healthy controls. CONCLUSIONS: The relatively small subject group means that the study may not detect subtle perturbations in hormone concentrations. A targeted study of the somatotropic axis in larger cohorts may be warranted. However, the lack of significant results despite many variables being tested does imply that the majority of them do not differ substantially between HD and controls. |
format | Online Article Text |
id | pubmed-4592185 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-45921852015-10-09 A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington’s Disease Kalliolia, Eirini Silajdžić, Edina Nambron, Rajasree Costelloe, Seán J. Martin, Nicholas G. Hill, Nathan R. Frost, Chris Watt, Hilary C. Hindmarsh, Peter Björkqvist, Maria Warner, Thomas T. PLoS One Research Article BACKGROUND: Huntington’s disease is an inherited neurodegenerative disorder characterised by motor, cognitive and psychiatric disturbances. Patients exhibit other symptoms including sleep and mood disturbances, muscle atrophy and weight loss which may be linked to hypothalamic pathology and dysfunction of hypothalamo-pituitary axes. METHODS: We studied neuroendocrine profiles of corticotropic, somatotropic and gonadotropic hypothalamo-pituitary axes hormones over a 24-hour period in controlled environment in 15 healthy controls, 14 premanifest and 13 stage II/III Huntington’s disease subjects. We also quantified fasting levels of vasopressin, oestradiol, testosterone, dehydroepiandrosterone sulphate, thyroid stimulating hormone, free triiodothyronine, free total thyroxine, prolactin, adrenaline and noradrenaline. Somatotropic axis hormones, growth hormone releasing hormone, insulin-like growth factor-1 and insulin-like factor binding protein-3 were quantified at 06:00 (fasting), 15:00 and 23:00. A battery of clinical tests, including neurological rating and function scales were performed. RESULTS: 24-hour concentrations of adrenocorticotropic hormone, cortisol, luteinizing hormone and follicle-stimulating hormone did not differ significantly between the Huntington’s disease group and controls. Daytime growth hormone secretion was similar in control and Huntington’s disease subjects. Stage II/III Huntington’s disease subjects had lower concentration of post-sleep growth hormone pulse and higher insulin-like growth factor-1:growth hormone ratio which did not reach significance. In Huntington’s disease subjects, baseline levels of hypothalamo-pituitary axis hormones measured did not significantly differ from those of healthy controls. CONCLUSIONS: The relatively small subject group means that the study may not detect subtle perturbations in hormone concentrations. A targeted study of the somatotropic axis in larger cohorts may be warranted. However, the lack of significant results despite many variables being tested does imply that the majority of them do not differ substantially between HD and controls. Public Library of Science 2015-10-02 /pmc/articles/PMC4592185/ /pubmed/26431314 http://dx.doi.org/10.1371/journal.pone.0138848 Text en © 2015 Kalliolia et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Kalliolia, Eirini Silajdžić, Edina Nambron, Rajasree Costelloe, Seán J. Martin, Nicholas G. Hill, Nathan R. Frost, Chris Watt, Hilary C. Hindmarsh, Peter Björkqvist, Maria Warner, Thomas T. A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington’s Disease |
title | A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington’s Disease |
title_full | A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington’s Disease |
title_fullStr | A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington’s Disease |
title_full_unstemmed | A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington’s Disease |
title_short | A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington’s Disease |
title_sort | 24-hour study of the hypothalamo-pituitary axes in huntington’s disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592185/ https://www.ncbi.nlm.nih.gov/pubmed/26431314 http://dx.doi.org/10.1371/journal.pone.0138848 |
work_keys_str_mv | AT kallioliaeirini a24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease AT silajdzicedina a24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease AT nambronrajasree a24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease AT costelloeseanj a24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease AT martinnicholasg a24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease AT hillnathanr a24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease AT frostchris a24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease AT watthilaryc a24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease AT hindmarshpeter a24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease AT bjorkqvistmaria a24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease AT warnerthomast a24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease AT kallioliaeirini 24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease AT silajdzicedina 24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease AT nambronrajasree 24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease AT costelloeseanj 24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease AT martinnicholasg 24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease AT hillnathanr 24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease AT frostchris 24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease AT watthilaryc 24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease AT hindmarshpeter 24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease AT bjorkqvistmaria 24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease AT warnerthomast 24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease |